30 October 2017 in Neuroscience and Behavioral Physiology
5 November 2021 in Consortium Psychiatricum
INTRODUCTION: The limited practice of depot antipsychotics and psychoeducation use, recommended for overcoming the noncompliance of patients with severe mental disorders, is linked to a high incidence of treatment violation. Therefore, the development of personalized mental healthcare approaches is a crucial healthcare task. AIM: To describe and differentiate the role of clinical, social and psychological factors that lead to different level of treatment engagement of psychiatric inpatients. METHODS: Secondary analysis of findings from 91 inpatients, based on the Treatment Motivation Assessment Questionnaire and Medication Compliance Scale, as well as the Scale of Internalized Stigma of Mental Illness and Perceived Discrimination and Devaluation Scale. Factorial analysis, cluster analysis and analysis of variance with p-level=0.05 and the calculation of the effect size (ES) according to Cohens d and Cramers V were used. RESULTS: The nature of therapy compliance in various categories of patients is mediated differentially, including: the severity of negative symptoms (ES=0.29), the global level of functioning and work maladjustment (ES=0.230.26), various motivational and behavioral styles (ES0.74) and the intensity of psychiatric stigmatization (ES0.88). CONCLUSIONS: Consideration of the clinical, social and psychological factors should empirically determine the strategies for the personalized use of prolonged antipsychotics and socio-psychotherapeutic interventions when developing an individual treatment plan for psychiatric in-patients.
5 August 2021 in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
Threats to life and health, the public health crisis associated with the COVID-19 pandemic, have led to 1) accelerated development of vaccines, 2) adverse psychological reactions in the population.Aim: to identify differences in stress, anxiety, protective behavior strategies, and the socio-demographic characteristics of online survey participants, who reported opposing attitudes to SARS-CoV-2 vaccination.Materials and Methods. In December 2020-January 2021, 131 respondents were assessed (men—21.4%). The Psychological Stress Scale (PSM 25), original questionnaires to evaluate pandemic concerns and protective behavior strategies with special question about COVID-19 vaccine acceptance were used. Effect sizes obtained using Cohen’s d and Cramer’s V measures were calculated for groups, the differences between which were significant (p≤0.05).Results. A 47.3% sample, having PSM-25 rates above the threshold (100 points), showed a distress reaction to the pandemic due to anxiety stress. Compared to the spring of 2020, the number of concerns associated with a noticeable stress growth (ES≥0.34) increased from two to six. Psychological distress, concerns about the possible lack of medication for daily intake, harsh social consequences and self-isolation were associated with only foreign producer vaccine acceptance (ES=0.3-0.5). Absence of excessive fears for own life, concerns about the lack of personal protective equipment and unacceptance of gloves as a measure to prevent infection (ES=0.3-0.4) were important factors associated with any producer vaccine acceptance. Men, comparing to women, were more positive in vaccine acceptance.Conclusion. The anxiety distress is an important factor in the rational attitude to coronavirus infection vaccine.
29 September 2023 in Consortium Psychiatricum
BACKGROUND: Psychiatric stigma has potentially controversial effects on patients health-related behaviors. It appears that both stigmatization and motivation in psychiatric patients are heterogeneous and multi-dimensional, and that the relationship between stigma and treatment motivation may be more complex than previously believed. AIM: To determine psychiatric stigma subtypes as they relate to treatment motivation among inpatients with various mental disorders. METHODS: Sixy-three psychiatric inpatients were examined by the Treatment Motivation Assessment Questionnaire (TMAQ) and the Russian version of Internalized Stigma of Mental Illness scale (ISMI). K-Means cluster and dispersion analysis were conducted. RESULTS: Cluster 3 (25 subjects) was the least stigmatized. Cluster 1 (18 subjects) showed an explicit stigma. Cluster 2 (20 subjects) showed an implicit stigma that took the form of the lowest treatment motivation compared to other clusters. Implicitly stigmatized patients, in contrast to explicitly stigmatized individuals, showed a decline in 3 out of 4 TMAQ factors (Mean dif.=1.051.67). CONCLUSION: Cooperation with doctors, together with reliance on ones own knowledge and skills to cope with the disorder, might be the way to overcome an internalized stigma for patients with mental disorders.
1 January 2016 in S.S. Korsakov Journal of Neurology and Psychiatry
Издательство Медиа Сфера - 25 медицинских журналов общим тиражом около 500 000 экземпляров в год, представлены в международных базах данных Scopus, Medline, и Google Scolar, включены в перечень изданий ВАК, представлены в РИНЦ